NYSE: BMY

Price$54.78 Change +0.19 %Change +0.35% Volume: 26,861,211 20 minute delay February 21, 2017

SEC Filings

Date Filing Description Download
Nov 15, 2000 SC 13D/A Amended Statement of Beneficial Ownership
Nov 14, 2000 SC 13D/A Amended Statement of Beneficial Ownership
Nov 14, 2000 10-Q Quarterly Report
Aug 15, 2000 10-Q Quarterly Report
Jun 30, 2000 11-K Annual Report of Employee Stock Plans
May 15, 2000 10-Q Quarterly Report
Apr 19, 2000 8-K Current report filing
Mar 30, 2000 10-K Annual Report
Mar 24, 2000 AR/S Paper Annual Report to Security Holders
Mar 20, 2000 DEF 14A Proxy Statement (definitive)
Mar 10, 2000 SC 13D/A Amended Statement of Beneficial Ownership
Feb 24, 2000 NO ACT Public response to a specific request for staff views regarding the federal securities laws or SEC rules, regulations or orders
Feb 21, 2000 NO ACT Public response to a specific request for staff views regarding the federal securities laws or SEC rules, regulations or orders
Feb 11, 2000 SC 13G/A Amended Statement of Ownership
Feb 11, 2000 SC 13G/A Amended Statement of Ownership
Feb 11, 2000 SC 13G/A Amended Statement of Ownership

Materials on this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents are available from the Securities and Exchange Commission, the Bristol-Myers Squibb website or from Bristol-Myers Squibb Investor Relations.

In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change, whether as a result of new information, future events or otherwise. Consequently, the company will not update the information contained on the website and investors should not rely upon the information as current or accurate after the presentation date. The website may also contain certain non-GAAP financial measures, adjusted to include certain costs, expenses, gains and losses and other specified items. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com.